La Roche-Posay tackles lockdown-induced acne

The derm brand has launched the first face and body purifying gel.

Acne is a global problem and not just for teenagers. Close to 40 per cent of adults worldwide suffer from acne, particularly women aged in their 30s and 40s.

The COVID-19 pandemic has caused an upsurge in acne breakouts by increasing the incidence of well-known triggers. Two of the leading causes of flare-ups are stress and anxiety, both of which have surged in people of all age groups.

With more people working from home, touching or picking the face has become more of an issue say dermatologists.

When the coronavirus crisis started, DIY beauty became a major trend. But experimenting with new cleansers and masks can lead to breakouts.

Other causes of blemishes and irritations include abandoning skincare routines, irritation caused by humidity buildup in closed-off face coverings and changing diet and exercise habits.

La Roche-Posay has long been a leader in acne treatment with its award-winning Effaclar Duo (+) Anti Acne Moisturiser and Serozinc, the cult status, multipurpose spray that soothes redness and blemishes in double-quick time.

The derm brand has launched Effaclar Micro-Peeling Purifying Gel, the first face and body purifying gel that reduces imperfections and marks and prevents recurrence.

Containing the highest percentage of salicylic acid (2%) in the Effaclar range, after four weeks of regular use blemishes are reduced by 51 per cent, blackheads by 16 per cent and pigmented marks by 57 per cent.

Suitable for even sensitive skin, the gel is available from Chemist Warehouse, Priceline, selected pharmacies and Adore Beauty. RRP $29.95.

Leave a comment:

Your email address will not be published. All fields are required

Advertisement
Advertisement